Chevy Chase Trust Portfolio holdings
Chevy Chase Trust is an investment management firm owned by the B.F. Saul family. It builds portfolios around global themes for high net worth individuals, families, endowments and institutions. Its themes include the clustering of wealth in productive hubs and the rise of molecular medicine. The firm picks individual stocks and bonds itself, with no outside managers and no funds of its own.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ascendis Pharma A/S
ASND
|
+$92.1M |
| 2 |
Capital Group Growth ETF
CGGR
|
+$40M |
| 3 |
Bloom Energy
BE
|
+$33.8M |
| 4 |
Ferguson
FERG
|
+$22.2M |
| 5 |
Itaú Unibanco
ITUB
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$25.7M |
| 2 |
Electronic Arts
EA
|
+$22.3M |
| 3 |
Costco
COST
|
+$20.9M |
| 4 |
BWX Technologies
BWXT
|
+$19.6M |
| 5 |
Goldman Sachs
GS
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.84% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 10.6% |
| 4 | Communication Services | 9.52% |
| 5 | Consumer Discretionary | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
Amrize Ltd
AMRZ
$21.8B
| – | – |
-4,385
| Closed | -$234K | – |
|
677
Ralliant Corp
RAL
$7.62B
| – | – |
-2,885
| Closed | -$212K | – |
|
Similar funds
Chevy Chase Trust's Q3 2026 Portfolio in Review
As of Q3 2026, Chevy Chase Trust held 677 positions worth $40.4B, up 3.8% from $39B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Chevy Chase Trust's Q3 2026 filing shows 28 new, 357 increased, 241 reduced and 20 closed positions. Its largest new stake was Ascendis Pharma A/S: 363,640 shares worth $82.8M. The largest sale was iShares Core S&P 500 ETF, an estimated $25.7M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 37% a quarter earlier, followed by Financials and Healthcare.
- Chevy Chase Trust's largest Q3 2026 buy was Ascendis Pharma A/S: 363,640 shares worth $82.8M.
- Chevy Chase Trust added most to Itaú Unibanco in Q3 2026, an estimated $18.8M increase.
- Chevy Chase Trust's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $25.7M.
- Chevy Chase Trust fully exited Electronic Arts in Q3 2026, selling an estimated $22.3M.
- Chevy Chase Trust's ten largest holdings make up 38% of its $40.4B portfolio in Q3 2026.
- Chevy Chase Trust opened 28 new positions and closed 20 in Q3 2026.
- Chevy Chase Trust's portfolio value rose 3.8% quarter-over-quarter to $40.4B.
Based on Chevy Chase Trust's 13F filing for Q3 2026, filed 13 Nov 2026.